Хайлтын үр дүнгүүд - Mark Frasier
- 26-н 1 - 20 үр дүнгүүдийг харуулж байна
- Дараагийн хуудас руу очих
-
1
-
2
-
3
Discovery of Parkinson's disease states and disease progression modelling: a longitudinal data study using machine learning -н Kristen Severson, Lana M. Chahine, Luba Smolensky, Murtaza Dhuliawala, Mark Frasier, Kenney Ng, Soumya Ghosh, Jianying Hu
Хэвлэсэн 2021Artigo -
4
Loss of Leucine-Rich Repeat Kinase 2 (LRRK2) in Rats Leads to Progressive Abnormal Phenotypes in Peripheral Organs -н Marco A. S. Baptista, Kuldip D. Dave, Mark Frasier, Todd Sherer, Melanie A. Greeley, Melissa J. Beck, Julie S. Varsho, George A. Parker, Cindy Moore, Madeline J. Churchill, Charles K. Meshul, Brian Fiske
Хэвлэсэн 2013Artigo -
5
Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson’s disease -н Lori N. Eidson, George T. Kannarkat, Christopher J. Barnum, Jianjun Chang, Jaegwon Chung, Chelsea Caspell‐Garcia, Peggy Taylor, Brit Mollenhauer, Michael G. Schlossmacher, Larry Ereshefsky, Mark Yen, Catherine Kopil, Mark Frasier, Kenneth Marek, Vicki Hertzberg, Malú G. Tansey
Хэвлэсэн 2017Artigo -
6
The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort -н Un Jung Kang, Jennifer G. Goldman, Roy N. Alcalay, Tao Xie, Paul Tuite, Claire Henchcliffe, Penelope Hogarth, Amy W. Amara, Samuel Frank, Alice Rudolph, Cynthia Casaceli, Howard Andrews, Katrina Gwinn, Margaret Sutherland, Catherine Kopil, Lona Vincent, Mark Frasier
Хэвлэсэн 2016Artigo -
7
A user's guide for α‐synuclein biomarker studies in biological fluids: Perianalytical considerations -н Brit Mollenhauer, Richard Batrla, Omar M. A. El‐Agnaf, Douglas Galasko, Hilal A. Lashuel, Kalpana Merchant, Lesley M. Shaw, Dennis J. Selkoe, Robert M. Umek, Hugo Vanderstichele, Henrik Zetterberg, Jing Zhang, Chelsea Caspell‐Garcia, Christopher S. Coffey, Samantha J. Hutten, Mark Frasier, Peggy Taylor
Хэвлэсэн 2017Revisão -
8
Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features -н Jennifer G. Goldman, Howard Andrews, Amy W. Amara, Anna Naito, Roy N. Alcalay, Leslie M. Shaw, Peggy Taylor, Tao Xie, Paul Tuite, Claire Henchcliffe, Penelope Hogarth, Samuel Frank, Marie Saint‐Hilaire, Mark Frasier, Vanessa Arnedo, Alyssa Reimer, Margaret Sutherland, Christine Swanson‐Fischer, Katrina Gwinn, Un Jung Kang
Хэвлэсэн 2017Artigo -
9
Longitudinal analyses of cerebrospinal fluid α‐Synuclein in prodromal and early Parkinson's disease -н Brit Mollenhauer, Chelsea Caspell‐Garcia, Christopher S. Coffey, Peggy Taylor, Andy Singleton, Leslie M. Shaw, John Q. Trojanowski, Mark Frasier, Tanya Simuni, Àlex Iranzo, Wolfgang H. Oertel, Andrew Siderowf, Daniel Weintraub, John Seibyl, Arthur W. Toga, Caroline M. Tanner, Karl Kieburtz, Lana M. Chahine, Kenneth Marek, Douglas Galasko
Хэвлэсэн 2019Artigo -
10
Phenotypic characterization of recessive gene knockout rat models of Parkinson's disease -н Kuldip D. Dave, Shehan De Silva, Niketa P. Sheth, Sylvie Ramboz, Melissa J. Beck, Changyu Quang, Robert C. Switzer, S. Omar Ahmad, Susan M. Sunkin, Dan B. Walker, Xiaoxia Cui, Daniel A.C. Fisher, Aaron McCoy, Kevin Gamber, Xiaodong Ding, Matthew S. Goldberg, Stanley A. Benkovic, Meredith Haupt, Marco A. S. Baptista, Brian Fiske, Todd Sherer, Mark Frasier
Хэвлэсэн 2014Artigo -
11
Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort -н Tanya Simuni, Andrew Siderowf, Shirley Lasch, Christopher S. Coffey, Chelsea Caspell‐Garcia, Danna Jennings, Caroline M. Tanner, John Q. Trojanowski, Leslie M. Shaw, John Seibyl, Norbert Schuff, Andrew Singleton, Karl Kieburtz, Arthur W. Toga, Brit Mollenhauer, Doug Galasko, Lana M. Chahine, Daniel Weintraub, Tatiana Foroud, Duygu Tosun, Kathleen L. Poston, Vanessa Arnedo, Mark Frasier, Todd Sherer, Sohini Chowdhury, Kenneth Marek
Хэвлэсэн 2018Artigo -
12
The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort -н Kenneth Marek, Sohini Chowdhury, Andrew Siderowf, Shirley Lasch, Christopher S. Coffey, Chelsea Caspell‐Garcia, Tanya Simuni, Danna Jennings, Caroline M. Tanner, John Q. Trojanowski, Leslie M. Shaw, John Seibyl, Norbert Schuff, Andrew Singleton, Karl Kieburtz, Arthur W. Toga, Brit Mollenhauer, Doug Galasko, Lana M. Chahine, Daniel Weintraub, Tatiana Foroud, Duygu Tosun, Kathleen L. Poston, Vanessa Arnedo, Mark Frasier, Todd Sherer
Хэвлэсэн 2018Artigo -
13
Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression -н Brit Mollenhauer, Mohammed Dakna, Niels Kruse, Douglas Galasko, Tatiana Foroud, Henrik Zetterberg, Sebastian Schade, Roland G. Gera, Wenting Wang, Feng Gao, Mark Frasier, Lana M. Chahine, Christopher S. Coffey, Andrew Singleton, Tanya Simuni, Daniel Weintraub, John Seibyl, Arthur W. Toga, Caroline M. Tanner, Karl Kieburtz, Kenneth Marek, Andrew Siderowf, Jesse M. Cedarbaum, Samantha J. Hutten, Claudia Trenkwalder, Danielle Graham
Хэвлэсэн 2020Artigo -
14
CSF biomarkers associated with disease heterogeneity in early Parkinson’s disease: the Parkinson’s Progression Markers Initiative study -н Ju‐Hee Kang, Brit Mollenhauer, Christopher S. Coffey, Jon B. Toledo, Daniel Weintraub, Douglas Galasko, David J. Irwin, Vivianna M. Van Deerlin, Alice Chen‐Plotkin, Chelsea Caspell‐Garcia, Teresa Waligórska, Peggy Taylor, Nirali Shah, Sarah Pan, Paweł Żero, Mark Frasier, Kenneth Marek, Karl Kieburtz, Danna Jennings, Caroline M. Tanner, Tanya Simuni, Andrew Singleton, Arthur W. Toga, Sohini Chowdhury, John Q. Trojanowski, Leslie M. Shaw
Хэвлэсэн 2016Artigo -
15
A proteogenomic view of Parkinson’s disease causality and heterogeneity -н Sérgio Kaiser, Luqing Zhang, Brit Mollenhauer, Jaison Jacob, Simonne Longerich, Jorge L. Del-Águila, Jacob Marcus, Neha Raghavan, David J. Stone, Olumide Fagboyegun, Douglas Galasko, Mohammed Dakna, Bilada Bilican, Mary Dovlatyan, Anna Kostikova, Jingyao Li, Brant K. Peterson, Michael Rotte, Vinicius Sanz, Tatiana Foroud, Samantha J. Hutten, Mark Frasier, Hirotaka Iwaki, Andrew Singleton, Kenneth Marek, Karen Crawford, Fiona Elwood, Mirko Messa, Pablo Serrano‐Fernández
Хэвлэсэн 2023Artigo -
16
Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study -н Andrew Siderowf, Luis Concha‐Marambio, David-Erick Lafontant, Carly M. Farris, Yihua Ma, Paula A. Urenia, Hieu Nguyen, Roy N. Alcalay, Lana M. Chahine, Tatiana Foroud, Douglas Galasko, Karl Kieburtz, Kalpana Merchant, Brit Mollenhauer, Kathleen L. Poston, John Seibyl, Tanya Simuni, Caroline M. Tanner, Daniel Weintraub, Aleksandar Videnović, Seung Ho Choi, Ryan Kurth, Chelsea Caspell‐Garcia, Christopher S. Coffey, Mark Frasier, Luís M. A. Oliveira, Samantha J. Hutten, Todd Sherer, Kenneth Marek, Claudio Soto
Хэвлэсэн 2023Artigo -
17
Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohorts -н Tien Dam, Gennaro Pagano, Michael C. Brumm, Caroline Gochanour, Kathleen L. Poston, Daniel Weintraub, Lana M. Chahine, Christopher S. Coffey, Caroline M. Tanner, Catherine Kopil, Yuge Xiao, Sohini Chowdhury, Luis Concha‐Marambio, Peter DiBiaso, Tatiana Foroud, Mark Frasier, Danna Jennings, Karl Kieburtz, Kalpana Merchant, Brit Mollenhauer, Thomas J. Montine, Kelly Nudelman, John Seibyl, Todd Sherer, Andrew Singleton, Diane Stephenson, Matthew Stern, Claudio Soto, Eduardo Tolosa, Andrew Siderowf, Billy Dunn, Tanya Simuni, Kenneth Marek
Хэвлэсэн 2024Artigo -
18
Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study -н Mike A. Nalls, Cory Y. McLean, Jacqueline Rick, Shirley Eberly, Samantha J. Hutten, Katrina Gwinn, Margaret Sutherland, María Martínez, Peter Heutink, Nigel Williams, John Hardy, Thomas Gasser, Alexis Brice, T. Ryan Price, Aude Nicolas, Margaux F. Keller, Cliona Molony, J. Raphael Gibbs, Alice Chen‐Plotkin, EunRan Suh, Christopher Letson, Massimo S. Fiandaca, Mark Mapstone, Howard J. Federoff, Alastair Noyce, Huw R. Morris, Vivianna M. Van Deerlin, Daniel Weintraub, Cyrus P. Zabetian, Dena G. Hernandez, Suzanne Lesage, Meghan Mullins, Emily Drabant Conley, Carrie A. M. Northover, Mark Frasier, Kenneth Marek, Aaron Day-Williams, David J. Stone, John P. A. Ioannidis, Andrew Singleton
Хэвлэсэн 2015Artigo -
19
Finding useful biomarkers for Parkinson’s disease -н Alice Chen‐Plotkin, Roger L. Albin, Roy N. Alcalay, Debra Babcock, Vikram S. Bajaj, Dubois Bowman, Alex Buko, Jesse M. Cedarbaum, Daniel Chelsky, Mark Cookson, Ted M. Dawson, Richard B. Dewey, Tatiana Foroud, Mark Frasier, Dwight C. German, Katrina Gwinn, Xuemei Huang, Catherine Kopil, Thomas Kremer, Shirley Lasch, Kenneth Marek, Jarrod A. Marto, Kalpana Merchant, Brit Mollenhauer, Anna Naito, Judith A. Potashkin, Alyssa Reimer, Liana S. Rosenthal, Rachel Saunders‐Pullman, Clemens R. Scherzer, Todd Sherer, Andrew Singleton, Margaret Sutherland, Ines Thiele, Marcel van der Brug, Kendall Van Keuren‐Jensen, David E. Vaillancourt, David R. Walt, Andrew B. West, Jing Zhang
Хэвлэсэн 2018Revisão -
20
Precompetitive Consensus Building to Facilitate the Use of Digital Health Technologies to Support Parkinson Disease Drug Development through Regulatory Science -н Diane Stephenson, Robert Alexander, Varun Aggarwal, Reham Badawy, Lisa J. Bain, Roopal Bhatnagar, Bastiaan R. Bloem, Babak Boroojerdi, Jackson Burton, Jesse M. Cedarbaum, Joshua D. Cosman, David T. Dexter, Marissa F. Dockendorf, E. Ray Dorsey, Ariel V. Dowling, Luc J. W. Evers, Katherine Fisher, Mark Frasier, Luis Garcia‐Gancedo, Jennifer C. Goldsack, David Hill, Janice M. Hitchcock, Joshua Shulman, Michael P. Lawton, Sang Hyuck Lee, Michael Lindemann, Kenneth Marek, Nitin Mehrotra, Marjan J. Meinders, Michael Minchik, Lauren Oliva, Klaus Romero, George Roussos, Robert Rubens, Sakshi Sadar, J. Scheeren, Eiichi Sengoku, Tanya Simuni, Glenn T. Stebbins, Kirsten I. Taylor, Beatrice Yang, Neta Zach
Хэвлэсэн 2020Revisão
Хайх хэрэгслүүд:
Холбогдох сэдвүүд
Medicine
Disease
Parkinson's disease
Internal medicine
Pathology
Biology
Biochemistry
Biomarker
Cohort
Oncology
Psychology
Alpha-synuclein
Bioinformatics
Chemistry
Gastroenterology
Neuroscience
Psychiatry
Cerebrospinal fluid
Cohort study
Dopamine
Drug
Endocrinology
Gene
Clinical trial
Dementia
Dopaminergic
Genetics
LRRK2
Neurodegeneration
Physical medicine and rehabilitation